Turnover and tissue sites of degradation of glucosylated low density lipoprotein in normal and immunized rabbits
Immunological mechanisms have been implicated in the atherogenic process since immunoglobulins are frequently found in the atherosclerotic aorta. We have previously shown that modifications of homologous low density lipoproteins (LDL) make it immunogenic. In particular we have demonstrated that immu...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
1987-09-01
|
Series: | Journal of Lipid Research |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0022227520386235 |
_version_ | 1818460019669073920 |
---|---|
author | O Wiklund J L Witztum T E Carew R C Pittman R L Elam D Steinberg |
author_facet | O Wiklund J L Witztum T E Carew R C Pittman R L Elam D Steinberg |
author_sort | O Wiklund |
collection | DOAJ |
description | Immunological mechanisms have been implicated in the atherogenic process since immunoglobulins are frequently found in the atherosclerotic aorta. We have previously shown that modifications of homologous low density lipoproteins (LDL) make it immunogenic. In particular we have demonstrated that immunization with homologous nonenzymatically glucosylated LDL (glcLDL) results in the generation of antibodies specific to the derivatized lysine residue, and that such antibodies do not react with native LDL epitopes. In the present study we immunized rabbits with reductively glucosylated rabbit LDL and then determined the effects of the circulating antibodies on the rates of plasma clearance and on the sites of degradation of LDL in which varying degrees of glucosylation had been achieved. In normal chow-fed animals, the plasma clearance of glcLDL was retarded in proportion to the extent of lysine derivatization. In contrast, in immunized animals the clearance of glcLDL was greatly accelerated. When 10% or more of lysine residues were derivatized, clearance of glcLDL was accelerated 50- to 100-fold. Even when only 5% of lysines were derivatized, plasma clearance was accelerated 2- to 3-fold. Cholesterol feeding inhibited LDL clearance from plasma and decreased LDL uptake of LDL receptor-rich tissues. In a similar manner, glucosylation of LDL inhibited its ability to bind to the LDL receptor and redirected sites of LDL degradation away from LDL receptor-rich tissues. Thus degradation of glcLDL by liver and adrenal was markedly diminished. The presence of antibodies to glcLDL also redirected sites of degradation of the modified LDL, primarily to the reticuloendothelial cells of the liver. There was no evidence for specific targeting of glcLDL-immunoglobulin complexes to the aorta; instead they were targeted to the liver. These data suggest that the presence of humoral antibodies to modified LDL acts to rapidly remove such LDL from plasma and specifically targets such complexes to reticuloendothelial cells, primarily in the liver. In this manner such antibodies may serve a useful purpose. |
first_indexed | 2024-12-14T23:23:36Z |
format | Article |
id | doaj.art-ea8f865b75344e14951cb4a960449b91 |
institution | Directory Open Access Journal |
issn | 0022-2275 |
language | English |
last_indexed | 2024-12-14T23:23:36Z |
publishDate | 1987-09-01 |
publisher | Elsevier |
record_format | Article |
series | Journal of Lipid Research |
spelling | doaj.art-ea8f865b75344e14951cb4a960449b912022-12-21T22:43:52ZengElsevierJournal of Lipid Research0022-22751987-09-0128910981109Turnover and tissue sites of degradation of glucosylated low density lipoprotein in normal and immunized rabbitsO Wiklund0J L Witztum1T E Carew2R C Pittman3R L Elam4D Steinberg5Department of Medicine, University of California, San Diego, La Jolla 92093.Department of Medicine, University of California, San Diego, La Jolla 92093.Department of Medicine, University of California, San Diego, La Jolla 92093.Department of Medicine, University of California, San Diego, La Jolla 92093.Department of Medicine, University of California, San Diego, La Jolla 92093.Department of Medicine, University of California, San Diego, La Jolla 92093.Immunological mechanisms have been implicated in the atherogenic process since immunoglobulins are frequently found in the atherosclerotic aorta. We have previously shown that modifications of homologous low density lipoproteins (LDL) make it immunogenic. In particular we have demonstrated that immunization with homologous nonenzymatically glucosylated LDL (glcLDL) results in the generation of antibodies specific to the derivatized lysine residue, and that such antibodies do not react with native LDL epitopes. In the present study we immunized rabbits with reductively glucosylated rabbit LDL and then determined the effects of the circulating antibodies on the rates of plasma clearance and on the sites of degradation of LDL in which varying degrees of glucosylation had been achieved. In normal chow-fed animals, the plasma clearance of glcLDL was retarded in proportion to the extent of lysine derivatization. In contrast, in immunized animals the clearance of glcLDL was greatly accelerated. When 10% or more of lysine residues were derivatized, clearance of glcLDL was accelerated 50- to 100-fold. Even when only 5% of lysines were derivatized, plasma clearance was accelerated 2- to 3-fold. Cholesterol feeding inhibited LDL clearance from plasma and decreased LDL uptake of LDL receptor-rich tissues. In a similar manner, glucosylation of LDL inhibited its ability to bind to the LDL receptor and redirected sites of LDL degradation away from LDL receptor-rich tissues. Thus degradation of glcLDL by liver and adrenal was markedly diminished. The presence of antibodies to glcLDL also redirected sites of degradation of the modified LDL, primarily to the reticuloendothelial cells of the liver. There was no evidence for specific targeting of glcLDL-immunoglobulin complexes to the aorta; instead they were targeted to the liver. These data suggest that the presence of humoral antibodies to modified LDL acts to rapidly remove such LDL from plasma and specifically targets such complexes to reticuloendothelial cells, primarily in the liver. In this manner such antibodies may serve a useful purpose.http://www.sciencedirect.com/science/article/pii/S0022227520386235 |
spellingShingle | O Wiklund J L Witztum T E Carew R C Pittman R L Elam D Steinberg Turnover and tissue sites of degradation of glucosylated low density lipoprotein in normal and immunized rabbits Journal of Lipid Research |
title | Turnover and tissue sites of degradation of glucosylated low density lipoprotein in normal and immunized rabbits |
title_full | Turnover and tissue sites of degradation of glucosylated low density lipoprotein in normal and immunized rabbits |
title_fullStr | Turnover and tissue sites of degradation of glucosylated low density lipoprotein in normal and immunized rabbits |
title_full_unstemmed | Turnover and tissue sites of degradation of glucosylated low density lipoprotein in normal and immunized rabbits |
title_short | Turnover and tissue sites of degradation of glucosylated low density lipoprotein in normal and immunized rabbits |
title_sort | turnover and tissue sites of degradation of glucosylated low density lipoprotein in normal and immunized rabbits |
url | http://www.sciencedirect.com/science/article/pii/S0022227520386235 |
work_keys_str_mv | AT owiklund turnoverandtissuesitesofdegradationofglucosylatedlowdensitylipoproteininnormalandimmunizedrabbits AT jlwitztum turnoverandtissuesitesofdegradationofglucosylatedlowdensitylipoproteininnormalandimmunizedrabbits AT tecarew turnoverandtissuesitesofdegradationofglucosylatedlowdensitylipoproteininnormalandimmunizedrabbits AT rcpittman turnoverandtissuesitesofdegradationofglucosylatedlowdensitylipoproteininnormalandimmunizedrabbits AT rlelam turnoverandtissuesitesofdegradationofglucosylatedlowdensitylipoproteininnormalandimmunizedrabbits AT dsteinberg turnoverandtissuesitesofdegradationofglucosylatedlowdensitylipoproteininnormalandimmunizedrabbits |